Cardiovascular responses to diazepam and midazolam maleate in the dog

D. J. Jones, L. C. Stehling, H. L. Zauder

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Previous clinical studies establishing the efficacy of midazolam maleate (RO 21-3981), a new water-soluble benzodiazepine for induction of anesthesia, have not critically evaluated the effects of this agent on the cardiovascular system. The present study compares the cardiovascular effects of midazolam maleate and diazepam in conscious dogs. Systemic arterial, pulmonary arterial and central venous pressures, cardiac output, LV(max) dP/dt, heart rate and regional coronary blood flow were measured 3 min following intravenous administration of diazepam (0.5, 1.0 and 2.5 mg/kg) or midazolam maleate (0.25, 1.0, and 10.0 mg/kg). Midazolam maleate increased heart rate 10-20% with all three doses and decreased mean arterial blood pressure approximately 10-20% at 1.0 and 10 mg/kg. Cardiac output was increased 10-12% with all three doses of midazolam maleate, and LV(max) dP/dt was decreased 13-16% at the two higher doses. Diazepam at all three doses did not alter heart rate or mean arterial blood pressure. Diazepam, 1.0 and 2.5 mg/kg, produced significant (17%) decreases in LV(max) dP/dt, and 2.5 mg/kg produced a significant (10%) increase in cardiac output. Neither drug in any dosage altered regional coronary blood flow, systemic or coronary vascular resistance, stroke volume, or stroke work. Maximum alterations in cardiovascular variables occurred with doses of midazolam maleate that are 10-15 times the recommended clinical induction dosage. It is conluded that in concentrations necessary for induction of anesthesia midazolam maleate has minimal effects on cardiovascular function.

Original languageEnglish (US)
Pages (from-to)430-434
Number of pages5
JournalAnesthesiology
Volume51
Issue number5
StatePublished - 1979

Fingerprint

Midazolam
Diazepam
Dogs
Arterial Pressure
Cardiac Output
Heart Rate
Regional Blood Flow
Anesthesia
Central Venous Pressure
Cardiovascular System
Benzodiazepines
Intravenous Administration
Vascular Resistance
Stroke Volume
Stroke
Lung
Water
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Jones, D. J., Stehling, L. C., & Zauder, H. L. (1979). Cardiovascular responses to diazepam and midazolam maleate in the dog. Anesthesiology, 51(5), 430-434.

Cardiovascular responses to diazepam and midazolam maleate in the dog. / Jones, D. J.; Stehling, L. C.; Zauder, H. L.

In: Anesthesiology, Vol. 51, No. 5, 1979, p. 430-434.

Research output: Contribution to journalArticle

Jones, DJ, Stehling, LC & Zauder, HL 1979, 'Cardiovascular responses to diazepam and midazolam maleate in the dog', Anesthesiology, vol. 51, no. 5, pp. 430-434.
Jones DJ, Stehling LC, Zauder HL. Cardiovascular responses to diazepam and midazolam maleate in the dog. Anesthesiology. 1979;51(5):430-434.
Jones, D. J. ; Stehling, L. C. ; Zauder, H. L. / Cardiovascular responses to diazepam and midazolam maleate in the dog. In: Anesthesiology. 1979 ; Vol. 51, No. 5. pp. 430-434.
@article{557c74bd70bb4d56a41a9a25f0647e62,
title = "Cardiovascular responses to diazepam and midazolam maleate in the dog",
abstract = "Previous clinical studies establishing the efficacy of midazolam maleate (RO 21-3981), a new water-soluble benzodiazepine for induction of anesthesia, have not critically evaluated the effects of this agent on the cardiovascular system. The present study compares the cardiovascular effects of midazolam maleate and diazepam in conscious dogs. Systemic arterial, pulmonary arterial and central venous pressures, cardiac output, LV(max) dP/dt, heart rate and regional coronary blood flow were measured 3 min following intravenous administration of diazepam (0.5, 1.0 and 2.5 mg/kg) or midazolam maleate (0.25, 1.0, and 10.0 mg/kg). Midazolam maleate increased heart rate 10-20{\%} with all three doses and decreased mean arterial blood pressure approximately 10-20{\%} at 1.0 and 10 mg/kg. Cardiac output was increased 10-12{\%} with all three doses of midazolam maleate, and LV(max) dP/dt was decreased 13-16{\%} at the two higher doses. Diazepam at all three doses did not alter heart rate or mean arterial blood pressure. Diazepam, 1.0 and 2.5 mg/kg, produced significant (17{\%}) decreases in LV(max) dP/dt, and 2.5 mg/kg produced a significant (10{\%}) increase in cardiac output. Neither drug in any dosage altered regional coronary blood flow, systemic or coronary vascular resistance, stroke volume, or stroke work. Maximum alterations in cardiovascular variables occurred with doses of midazolam maleate that are 10-15 times the recommended clinical induction dosage. It is conluded that in concentrations necessary for induction of anesthesia midazolam maleate has minimal effects on cardiovascular function.",
author = "Jones, {D. J.} and Stehling, {L. C.} and Zauder, {H. L.}",
year = "1979",
language = "English (US)",
volume = "51",
pages = "430--434",
journal = "Anesthesiology",
issn = "0003-3022",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Cardiovascular responses to diazepam and midazolam maleate in the dog

AU - Jones, D. J.

AU - Stehling, L. C.

AU - Zauder, H. L.

PY - 1979

Y1 - 1979

N2 - Previous clinical studies establishing the efficacy of midazolam maleate (RO 21-3981), a new water-soluble benzodiazepine for induction of anesthesia, have not critically evaluated the effects of this agent on the cardiovascular system. The present study compares the cardiovascular effects of midazolam maleate and diazepam in conscious dogs. Systemic arterial, pulmonary arterial and central venous pressures, cardiac output, LV(max) dP/dt, heart rate and regional coronary blood flow were measured 3 min following intravenous administration of diazepam (0.5, 1.0 and 2.5 mg/kg) or midazolam maleate (0.25, 1.0, and 10.0 mg/kg). Midazolam maleate increased heart rate 10-20% with all three doses and decreased mean arterial blood pressure approximately 10-20% at 1.0 and 10 mg/kg. Cardiac output was increased 10-12% with all three doses of midazolam maleate, and LV(max) dP/dt was decreased 13-16% at the two higher doses. Diazepam at all three doses did not alter heart rate or mean arterial blood pressure. Diazepam, 1.0 and 2.5 mg/kg, produced significant (17%) decreases in LV(max) dP/dt, and 2.5 mg/kg produced a significant (10%) increase in cardiac output. Neither drug in any dosage altered regional coronary blood flow, systemic or coronary vascular resistance, stroke volume, or stroke work. Maximum alterations in cardiovascular variables occurred with doses of midazolam maleate that are 10-15 times the recommended clinical induction dosage. It is conluded that in concentrations necessary for induction of anesthesia midazolam maleate has minimal effects on cardiovascular function.

AB - Previous clinical studies establishing the efficacy of midazolam maleate (RO 21-3981), a new water-soluble benzodiazepine for induction of anesthesia, have not critically evaluated the effects of this agent on the cardiovascular system. The present study compares the cardiovascular effects of midazolam maleate and diazepam in conscious dogs. Systemic arterial, pulmonary arterial and central venous pressures, cardiac output, LV(max) dP/dt, heart rate and regional coronary blood flow were measured 3 min following intravenous administration of diazepam (0.5, 1.0 and 2.5 mg/kg) or midazolam maleate (0.25, 1.0, and 10.0 mg/kg). Midazolam maleate increased heart rate 10-20% with all three doses and decreased mean arterial blood pressure approximately 10-20% at 1.0 and 10 mg/kg. Cardiac output was increased 10-12% with all three doses of midazolam maleate, and LV(max) dP/dt was decreased 13-16% at the two higher doses. Diazepam at all three doses did not alter heart rate or mean arterial blood pressure. Diazepam, 1.0 and 2.5 mg/kg, produced significant (17%) decreases in LV(max) dP/dt, and 2.5 mg/kg produced a significant (10%) increase in cardiac output. Neither drug in any dosage altered regional coronary blood flow, systemic or coronary vascular resistance, stroke volume, or stroke work. Maximum alterations in cardiovascular variables occurred with doses of midazolam maleate that are 10-15 times the recommended clinical induction dosage. It is conluded that in concentrations necessary for induction of anesthesia midazolam maleate has minimal effects on cardiovascular function.

UR - http://www.scopus.com/inward/record.url?scp=0018638850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018638850&partnerID=8YFLogxK

M3 - Article

C2 - 496058

AN - SCOPUS:0018638850

VL - 51

SP - 430

EP - 434

JO - Anesthesiology

JF - Anesthesiology

SN - 0003-3022

IS - 5

ER -